An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A social media post claimed that most people—more than 70%—feel very nauseated from GLP-1 drugs like Wegovy, and the poster says their own experience (severe nausea even after 12 weeks on a steady dose) makes them think the true rate is higher than what clinical studies report. They said they had to stop treatment immediately because the sickness was so bad. That’s the claim: lots of people get intense nausea from these medicines, maybe more than official numbers suggest. GLP-1 drugs are a class of medicines that mimic a natural gut hormone called glucagon-like peptide-1. That hormone helps control blood sugar and tells your brain you’ve eaten enough; it also slows how fast your stomach empties. Brands you’ve probably heard about include Ozempic and Wegovy. Scientists call these drugs “GLP-1 receptor agonists” — a fancy way of saying they copy the hormone’s action by sticking to the same receptors in the body. What the research actually shows is mixed but clearer than a single social-media post. Clinical trials for drugs like semaglutide (the active ingredient in Ozempic and Wegovy) often report nausea as the most common side effect. The numbers vary by study, dose, and whether people are new to the drug. Reported rates of nausea in trials are usually well under 70% for severe nausea; many people report mild or occasional nausea, and a smaller percentage report nausea bad enough to stop the drug. Real-world experience can differ from trials because trial participants are selected and monitored carefully, and reporting in the wild is uneven. A single person’s severe reaction doesn’t change the population-wide rates, but it’s a real and important example of what can happen. Why this matters: millions of people are taking GLP-1 drugs now for diabetes or weight loss. If nausea is common or sometimes severe, that affects how useful these drugs are for everyday life. People thinking about starting one need to know it might make them feel sick, at least at first, and some will not tolerate it. Doctors use strategies like starting at a low dose and increasing slowly to reduce nausea, and they weigh the benefits (improved blood sugar control, weight loss) against side effects for each patient. Caveats and risks: social-media posts are anecdotes — useful for raising questions, not for measuring how common something is. Clinical trials are more reliable for rates but may underestimate problems that show up once thousands more people use a drug. Nausea usually improves over time for many people, but not everyone — some must stop treatment. Other side effects exist (like vomiting, constipation, or, rarely, more serious issues) and certain people should avoid these drugs or use them cautiously — for example, those with a history of certain thyroid cancers, pancreatitis, or specific medical conditions. Always talk with a clinician before starting or stopping a prescription; sudden stopping can have consequences depending on why you were taking it. Bottom line: nausea is a known and common side effect of GLP-1 drugs, but a single person’s claim of >70% experiencing severe sickness doesn’t match clinical trial averages — still, individual experiences vary, and some people do get sick enough to quit.
Source: r/Semaglutide